5 Results for "

senktide

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "senktide" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-P0187
CAS No.: 106128-89-6
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease Endocrinology

Senktide is a potent, selective agonist of the neuromedin K3 (NK3) receptor (EC50=0.5-3 nM). Senktide less potently agonizes the NK1 receptor (EC50=35 µM). Senktide is promising for research of neurological disease .
loading...
    loading...
Cat. No.: HY-W755425
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease

Senktide TFA is a potent, selective agonist of the neuromedin K3 (NK3) receptor (EC50=0.5-3 nM). Senktide TFA less potently agonizes the NK1 receptor (EC50=35 µM). Senktide TFA is promising for research of neurological disease .
loading...
    loading...
Cat. No.: HY-129448
CAS No.: 825643-56-9
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease

RO4583298 is a potent, orally active dual antagonist of NK1 (human and gerbil)/NK3 (human, cynomolgus monkey, gerbil and guinea-pig). RO4583298 inhibits senktide-induced potentiation of spontaneous activity of dopaminergic neurons. RO4583298 can block gerbil foot tapping response and inhibits mouse tail whips .
loading...
    loading...
Cat. No.: HY-182423
CAS No.: 1310817-94-7
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease

RO5328673 is an orally active, blood-brain barrier permeable neurokinin receptor antagonist that effectively targets human NK3 receptors (Ki=0.4 nM, Ka=0.1 nM), human NK2 receptors (Ki=1.1 nM, Ka=0.9 nM), and guinea pig NK3 receptors (Ka=0.1 nM and 0.13 nM). RO5328673 acts as an insurmountable antagonist of NK3 receptors with a slow dissociation rate, while it shows rapid association and dissociation rates at human NK2 receptors. RO5328673 potently inhibits senktide (HY-P0187)-induced enhancement of spontaneous activity in dopaminergic neurons and reverses senktide-induced changes in motor activity of gerbils. RO5328673 is widely applicable to research related to schizophrenia .
loading...
    loading...
Cat. No.: HY-186284
CAS No.: 2245952-60-5
Target:  

Estrogen Receptor/ERR

Research Areas:  

Neurological Disease Endocrinology

EGX358 is a selective, orally active estrogen receptor β (ERβ) agonist with an EC50 of 27.4 nM for ERβ. EGX358 enhances object recognition ability, spatial memory and memory consolidation, and attenuates drug-induced vasomotor responses. EGX358 alleviates partial uterine atrophy without inducing uterine hypertrophy, while it does not alter anxiety-like behavior, depression-like behavior or body weight. EGX358 can be used in research related to Alzheimer's disease and menopause .
loading...
    loading...